Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE2

Conditions

Atopic Dermatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Novartis Investigative Site, Birmingham, Alabama, United States

  • Novartis Investigative Site, Birmingham, Alabama, United States

  • Novartis Investigative Site, Fort Smith, Arkansas, United States

  • Novartis Investigative Site, Fountain Valley, California, United States

  • Novartis Investigative Site, Los Angeles, California, United States

  • Novartis Investigative Site, Sacramento, California, United States

  • Novartis Investigative Site, Santa Ana, California, United States

  • Novartis Investigative Site, Santa Monica, California, United States

  • Novartis Investigative Site, Washington D.C., District of Columbia, United States

  • Novartis Investigative Site, Miami, Florida, United States

  • Novartis Investigative Site, Atlanta, Georgia, United States

  • Novartis Investigative Site, Macon, Georgia, United States

  • Novartis Investigative Site, Louisville, Kentucky, United States

  • Novartis Investigative Site, Brighton, Massachusetts, United States

  • Novartis Investigative Site, Troy, Michigan, United States

  • Novartis Investigative Site, Saint Joseph, Missouri, United States

  • Novartis Investigative Site, Brooklyn, New York, United States

  • Novartis Investigative Site, Arlington, Texas, United States

  • Novartis Investigative Site, Cypress, Texas, United States

  • Novartis Investigative Site, Dallas, Texas, United States

  • Novartis Investigative Site, Houston, Texas, United States

  • Novartis Investigative Site, San Antonio, Texas, United States

  • Novartis Investigative Site, Caba, Buenos Aires, Argentina

  • Novartis Investigative Site, Caba, Buenos Aires, Argentina

  • Novartis Investigative Site, Rosario, Santa Fe Province, Argentina

  • Novartis Investigative Site, Edmonton, Alberta, Canada

  • Novartis Investigative Site, Hamilton, Ontario, Canada

  • Novartis Investigative Site, Markham, Ontario, Canada

  • Novartis Investigative Site, Montreal, Quebec, Canada

  • Novartis Investigative Site, Verdun, Quebec, Canada

  • Novartis Investigative Site, Guangzhou, Guangdong, China

  • Novartis Investigative Site, Shantou, Guangdong, China

  • Novartis Investigative Site, Changsha, Hunan, China

  • Novartis Investigative Site, Changchun, Jilin, China

  • Novartis Investigative Site, Hangzhou, Zhejiang, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Shanghai, China

  • Novartis Investigative Site, Plzen Bory, Czechia

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Brest, France

  • Novartis Investigative Site, Lille, France

  • Novartis Investigative Site, Lorient, France

  • Novartis Investigative Site, Paris, France

  • Novartis Investigative Site, Pierre-Bénite, France

  • Novartis Investigative Site, Reims, France

  • Novartis Investigative Site, Rouen, France

  • Novartis Investigative Site, Frankfurt am Main, Hesse, Germany

  • Novartis Investigative Site, Mainz, Rhineland-Palatinate, Germany

  • Novartis Investigative Site, Bad Bentheim, Germany

  • Novartis Investigative Site, Dresden, Germany

  • Novartis Investigative Site, Hamburg, Germany

  • Novartis Investigative Site, Heidelberg, Germany

  • Novartis Investigative Site, Magdeburg, Germany

  • Novartis Investigative Site, Münster, Germany

  • Novartis Investigative Site, Oldenburg, Germany

  • Novartis Investigative Site, Pécs, Baranya, Hungary

  • Novartis Investigative Site, Debrecen, Hajdu Bihar Megye, Hungary

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Szeged, Hungary

  • Novartis Investigative Site, Ancona, AN, Italy

  • Novartis Investigative Site, Cona, FE, Italy

  • Novartis Investigative Site, Nagoya, Aichi-ken, Japan

  • Novartis Investigative Site, Matsudo, Chiba, Japan

  • Novartis Investigative Site, Kawasaki, Kanagawa, Japan

  • Novartis Investigative Site, Yokohama, Kanagawa, Japan

  • Novartis Investigative Site, Habikino, Osaka, Japan

  • Novartis Investigative Site, Shinagawa Ku, Tokyo, Japan

  • Novartis Investigative Site, Fukuoka, Japan

  • Novartis Investigative Site, Kyoto, Japan

  • Novartis Investigative Site, Rotterdam, South Holland, Netherlands

  • Novartis Investigative Site, Utrecht, Netherlands

  • Novartis Investigative Site, Warsaw, Masovian Voivodeship, Poland

  • Novartis Investigative Site, Katowice, Poland

  • Novartis Investigative Site, Lodz, Poland

  • Novartis Investigative Site, Lublin, Poland

  • Novartis Investigative Site, Warsaw, Poland

  • Novartis Investigative Site, Bardejov, Slovakia

  • Novartis Investigative Site, Komárno, Slovakia

  • Novartis Investigative Site, Košice, Slovakia

  • Novartis Investigative Site, Košice, Slovakia

  • Novartis Investigative Site, Prešov, Slovakia

  • Novartis Investigative Site, Ansan, Gyeonggi-do, South Korea

  • Novartis Investigative Site, Seoul, South Korea

  • Novartis Investigative Site, Badalona, Barcelona, Spain

  • Novartis Investigative Site, Alicante, Spain

  • Novartis Investigative Site, Granada, Spain

  • Novartis Investigative Site, Las Palmas GC, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Pontevedra, Spain

  • Novartis Investigative Site, Kaohsiung City, Taiwan

  • Novartis Investigative Site, Taipei, Taiwan

  • Novartis Investigative Site, Taipei, Taiwan

  • Novartis Investigative Site, Dudley, West Midlands, United Kingdom

  • Novartis Investigative Site, Liverpool, United Kingdom